Opinion
Published on: 30. January 2025

Fewer foreign pharmaceuticals: Healthcare reform causes controversy

Our "China Perspective" column is written by authors from the People's Republic. There have been heated discussions about China's healthcare system. The government has severely restricted access to branded foreign drugs in public hospitals. However, many doubt the effectiveness of domestic generic alternatives.

Sign up now and continue reading immediately

No credit card details required. No automatic renewal.

Sie haben bereits das Table.Briefing Abonnement?

Anmelden und weiterlesen
Last updated: 24. July 2025
Share
Copied!